Where is the biggest opportunity in preventative health: general wellness or specialized clinical testing and therapies?
4 recorded positions from 4 people, first said Nov 20, 2023. They do not agree — the readings below are what each one actually argued.
Consumer proactive health management is the next big category
Klaus Hommels · Nov 27, 2024 · hedged
Longitudinal preventative health screening has a very large market — far larger than most people assume
His own experience at the Lanserhof clinic showed him the value of tracking parameters over intervals with clear explanations of cause and effect, and people are becoming more health sensitive
Scope: framed as an implicit, subconsciously trained intuition rather than analysis
45:18 20VC: Why Price Sensitivity is BS | Why "Portfolios" are Merely a Construct to Make LPs Happy | Why the Best Investment Never Happen in "Fundraising Rounds" | What Europe Needs to do to Become a Superpower Again | Klaus Hommels, Lakestar
David George · Dec 15, 2025
Proactive personal health management will become a large, investable consumer category over the next ten years
It's one of the large consumer categories that hasn't hit yet, and the technology capabilities to support it will be there shortly
Scope: early today; the extreme version — AI coaching narrating the life-cost tradeoff of every decision — is too much; a more positive version is what will work
61:51 20VC: a16z's David George on How $BN Funds Can 5×, Do Margins & Revenue Matter in AI & the Most Controversial Bet at a16z
Also on the record
Matteo Franceschetti · Nov 20, 2023
The bed will become the most powerful preventative health platform and will save people's lives
88:13 Bed based continuous monitoring is the biggest preventative health opportunity
Andrew Dudum · Apr 4, 2026
The most interesting opportunity in preventative health right now is highly specialized testing and therapies for large unmet clinical areas like cardiovascular disease, not general wellness
Statins cost cents to manufacture and dramatically cut heart attack risk yet almost nobody takes them; biotech therapies delivering a single quarterly or annual injection could obliterate cardiovascular risk and bend the death rate
20:43 Specialized testing and therapies for major disease burden
Your assistant can query this graph directly — 4 positions here, 19,646 across the corpus. Add 996.fm over MCP.